ICPT
Intercept Pharmaceuticals, Inc.
ICPT
ICPT
Delisted
ICPT was delisted on the 7th of November, 2023.
214 hedge funds and large institutions have $3.2B invested in Intercept Pharmaceuticals, Inc. in 2019 Q4 according to their latest regulatory filings, with 50 funds opening new positions, 61 increasing their positions, 73 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
16% less call options, than puts
Call options by funds: $264M | Put options by funds: $314M
16% less repeat investments, than reductions
Existing positions increased: 61 | Existing positions reduced: 73
Holders
214
Holding in Top 10
4
Calls
$264M
Puts
$314M
Top Buyers
| 1 | +$56.5M | |
| 2 | +$30.9M | |
| 3 | +$22.7M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$18.2M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$12.4M |
Top Sellers
| 1 | -$44.5M | |
| 2 | -$38.1M | |
| 3 | -$33.3M | |
| 4 |
Goldman Sachs
New York
|
-$19.2M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$14.1M |